Erectile function after WST11 vascular-targeted photodynamic therapy for low-risk prostate cancer treatment

Vascular-targeted photodynamic therapy (VTP) using padeliporfin is currently assessed as a low-risk prostate cancer (LRPCa) treatment. The aim of this study was to assess erectile function outcomes of VTP for LRPCa treatment. We prospectively included all patients treated with VTP for LRPCa. The pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Chelly, Samuel, Maulaz, Pierre, Bigot, Pierre, Azzouzi, Abdel Rahmene, Lebdai, Souhil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523613/
https://www.ncbi.nlm.nih.gov/pubmed/31939351
http://dx.doi.org/10.4103/aja.aja_138_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523613/
https://www.ncbi.nlm.nih.gov/pubmed/31939351
http://dx.doi.org/10.4103/aja.aja_138_19

Ejemplares similares